André Kahan
About
André Kahan is a scholar working on Pathology and Forensic Medicine, Rheumatology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, André Kahan has authored 246 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Pathology and Forensic Medicine, 93 papers in Rheumatology and 48 papers in Pulmonary and Respiratory Medicine. Recurrent topics in André Kahan's work include Systemic Sclerosis and Related Diseases (117 papers), Rheumatoid Arthritis Research and Therapies (34 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (30 papers). André Kahan is often cited by papers focused on Systemic Sclerosis and Related Diseases (117 papers), Rheumatoid Arthritis Research and Therapies (34 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (30 papers). André Kahan collaborates with scholars based in France, Italy and Belgium. André Kahan's co-authors include Yannick Allanore, Jérôme Avouac, J. Wipff, Christophe Meune, Didier Borderie, É. Hachulla, B Amor, C J Menkès, Jean Sibilia and Ohvanesse G. Ekindjian and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Gastroenterology.
In The Last Decade
André Kahan
232 papers receiving 8.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| André Kahan France | 52 | 4.9k | 2.5k | 2.5k | 1.5k | 1.3k | 246 | 8.8k | ||
| Frank A. Wollheim Sweden | 33 | 4.1k 0.8× | 1.3k 0.5× | 1.9k 0.8× | 1.1k 0.8× | 1.6k 1.2× | 125 | 7.2k | ||
| Susanna Proudman Australia | 40 | 2.5k 0.5× | 1.6k 0.6× | 2.1k 0.9× | 945 0.6× | 861 0.6× | 251 | 5.7k | ||
| Ulrich A. Walker Switzerland | 42 | 2.3k 0.5× | 1.1k 0.4× | 1.1k 0.5× | 1.3k 0.9× | 1.2k 0.9× | 167 | 6.5k | ||
| Massimo Cugno Italy | 55 | 2.3k 0.5× | 356 0.1× | 3.2k 1.3× | 1.3k 0.9× | 2.2k 1.7× | 214 | 8.6k | ||
| H. Lévesque France | 45 | 1.2k 0.2× | 1.3k 0.5× | 1.4k 0.6× | 1.6k 1.1× | 741 0.6× | 295 | 7.0k | ||
| Xiaofeng Zeng China | 42 | 1.2k 0.2× | 3.1k 1.3× | 2.8k 1.1× | 1.2k 0.8× | 1.8k 1.3× | 488 | 9.2k | ||
| Jan Willem Cohen Tervaert Netherlands | 62 | 1.9k 0.4× | 7.7k 3.1× | 4.0k 1.6× | 948 0.6× | 3.5k 2.6× | 239 | 13.2k | ||
| Pnina Langevitz Israel | 50 | 1.1k 0.2× | 977 0.4× | 2.6k 1.1× | 817 0.6× | 3.0k 2.2× | 208 | 8.6k | ||
| Christine Mannhalter Austria | 58 | 1.3k 0.3× | 817 0.3× | 835 0.3× | 907 0.6× | 1.6k 1.2× | 338 | 10.9k | ||
| Solbritt Rantapää‐Dahlqvist Sweden | 61 | 1.1k 0.2× | 958 0.4× | 8.4k 3.4× | 911 0.6× | 3.7k 2.8× | 248 | 12.6k |
Countries citing papers authored by André Kahan
Since
Specialization
Citations
This map shows the geographic impact of André Kahan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Kahan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Kahan more than expected).
Fields of papers citing papers by André Kahan
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by André Kahan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Kahan. The network helps show where André Kahan may publish in the future.
Co-authorship network of co-authors of André Kahan
This figure shows the co-authorship network connecting the top 25 collaborators of André Kahan. A scholar is included among the top collaborators of André Kahan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Kahan. André Kahan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Avouac, Jérôme, Christophe Meune, Camille Chenevier‐Gobeaux, et al.. (2013). Inflammation and Disease Activity are Associated with High Circulating Cardiac Markers in Rheumatoid Arthritis Independently of Traditional Cardiovascular Risk Factors. The Journal of Rheumatology. 41(2). 248–255.
2.
Avouac, Jérôme, Eugénie Koumakis, Emese Tóth, et al.. (2012). Increased risk of osteoporosis and fracture in women with systemic sclerosis: A comparative study with rheumatoid arthritis. Arthritis Care & Research. 64(12). 1871–1878.
3.
Avouac, Jérôme, Barbara Ruiz, André Kahan, et al.. (2010). Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity. Arthritis Research & Therapy. 12(1). R27–R27.
4.
Avouac, Jérôme, Ulrich A. Walker, Alan Tyndall, et al.. (2010). Characteristics of Joint Involvement and Relationships with Systemic Inflammation in Systemic Sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) Database. The Journal of Rheumatology. 37(7). 1488–1501.
5.
Zerkak, D., J. Wipff, Daniel Dusser, et al.. (2009). Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases. European Respiratory Journal. 35(1). 112–117.
6.
Kahan, André, Daniel Uebelhart, Florent de Vathaire, Pierre D. Delmas, & Jean‐Yves Reginster. (2009). Long‐term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: The study on osteoarthritis progression prevention, a two‐year, randomized, double‐blind, placebo‐controlled trial. Arthritis & Rheumatism. 60(2). 524–533.
7.
Wipff, J., Matthieu Giraud, Jean Sibilia, et al.. (2008). Polymorphic markers of the fibrillin-1 gene and systemic sclerosis in European Caucasian patients.. PubMed. 35(4). 643–9.
8.
Allanore, Yannick, J. Wipff, André Kahan, & Cathérine Boileau. (2007). Genetic basis for systemic sclerosis. Joint Bone Spine. 74(6). 577–583.
9.
Kahan, André, E. Vignon, Daniel Uebelhart, & Jean‐Yves Reginster. (2007). A randomized controlled trial with chondroitin sulfate involving over 600 patients: STOPP (STudy on Osteoarthritis Progression Prevention). Open Repository and Bibliography (University of Liège).
10.
Reginster, Jean‐Yves, André Kahan, & E. Vignon. (2006). A two-year prospective, randomized, double-blind, controlled study assessing the effect of chondroitin 4&6 sulfate (CS) on the structural progression of knee osteoarthritis: STOPP (Study on Osteoarthritis Progression Prevention). Open Repository and Bibliography (University of Liège).
11.
Dequeker, J., Christopher J. Hawkey, André Kahan, et al.. (1998). Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX- inhibiting Therapies (SELECT) trial in osteoarthritis. Lara D. Veeken. 37(9). 946–951.
12.
Hawkey, C J, André Kahan, Klaus Steinbrück, et al.. (1998). Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment [published erratum appears in Br J Rheumatol 1998 Oct;37(10):1142]. Lara D. Veeken. 37(9). 937–945.
13.
Kahán, A, et al.. (1989). Increased proto‐oncogene expression in peripheral blood T lymphocytes from patients with systemic sclerosis. Arthritis & Rheumatism. 32(4). 430–436.
14.
Amor, B & André Kahan. (1989). Lacrimal and salivary immunoglobulins in Sjögren's syndrome. Journal of Autoimmunity. 2(4). 509–513.
15.
Chérìn, P., André Kahan, & B Amor. (1989). Manifestations neuro-rhumatologiques chez les patients infectés par le virus de l'immunodéficience acquise humaine.. 56(7).
16.
Dougados, Maxime, M Tulliez, André Kahan, et al.. (1987). Iléocolonoscopie systématique au cours des spondyloarthropathies séronégatives.. 54(3).
17.
Kahán, A, et al.. (1985). Different defects of T cell regulation of epstein‐barr virus‐induced B cell activation in rheumatoid arthritis. Arthritis & Rheumatism. 28(9). 961–970.
18.
Amor, B, et al.. (1977). [Hydroxyapatite rheumatism (multiple tendon calcification disease). II. - Microscopic study - HL-A antigen - Experimental arthritis - Pathogeny].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 44(5). 309–16.
19.
Amor, B, et al.. (1975). [W27 HL-A antigen. Diagnostic value in rheumatology].. PubMed. 42(2). 85–92.
20.
Béládi, I, et al.. (1963). AETIOLOGIC RELATIONSHIP OF ADENOVIRUS TYPE 8 TO THE EPIDEMIC OF KERATOCONJUNCTIVITIS IN SZEGED.. PubMed. 10. 59–63.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Frank A. Wollheim Breakdown of academic impact, for papers by Susanna Proudman Breakdown of academic impact, for papers by Ulrich A. Walker Breakdown of academic impact, for papers by Massimo Cugno Breakdown of academic impact, for papers by H. Lévesque Breakdown of academic impact, for papers by Xiaofeng Zeng Breakdown of academic impact, for papers by Jan Willem Cohen Tervaert Breakdown of academic impact, for papers by Pnina Langevitz Breakdown of academic impact, for papers by Christine Mannhalter Breakdown of academic impact, for papers by Solbritt Rantapää‐Dahlqvist